["{\n\"step_by_step_thinking\": \"Prevention of Rh haemolytic disease document emphasizes that the administration of anti-D immunoglobulin after normal deliveries and abortions can reduce the incidence of first-affected cases. There is no mention of a specific time frame for giving anti-D to pregnant patients, but it suggests administering anti-D antenatally might reduce the incidence of new cases among primigravidae who are sensitised before anti-D is normally given. This implies that timing may depend on individual patient circumstances. Swiss requirements for anti-D hyperimmunoglobulin also do not specify a particular time frame.\",\n\"answer_choice\": D"]